Differential expression of extracellular matrix components in the Fallopian tubes throughout the menstrual cycle

Reproductive Biology and Endocrinology

Volumn 10, Issue , 2012, Pages

  Diaz, Patricia S ^a,b   Solar, Paula A ^a,c   Juica, Natalia E ^a,c   Orihuela, Pedro A ^a,b   Cardenas, Hugo ^a,b   Christodoulides, Myron ^d   Vargas, Renato ^e   Velasquez, Luis A ^a,c  

^a CENTER FOR THE DEVELOPMENT OF NANOSCIENCE AND NANOTECHNOLOGY CEDENNA   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

^c UNIVERSIDAD ANDRÉS BELLO   (Chile)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e HOSPITAL SAN JOSÉ   (Chile)

Author keywords

Extracellular matrix; Fallopian tubes; Menstrual cycle; Metalloproteinases

Indexed keywords

ADAMTS1 PROTEIN; CD31 ANTIGEN; COLLAGEN TYPE 7; GELATINASE B; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE 16; METALLOPROTEINASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 2; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; BIOINFORMATICS; CONTROLLED STUDY; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FEMALE; FEMALE GENITAL SYSTEM; FOLLICULAR PHASE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; MENSTRUAL CYCLE; POLYMERASE CHAIN REACTION; PROTEIN LOCALIZATION; UTERINE TUBE; UTERINE TUBE MUCOSA; ZYMOGRAPHY;

ADULT; COMPUTATIONAL BIOLOGY; EXTRACELLULAR MATRIX PROTEINS; FALLOPIAN TUBES; FEMALE; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MENSTRUAL CYCLE; TRANSCRIPTOME;

EID: 84864962620     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-10-56     Document Type: Article

References (40)

1. Elkington PT, O'Kane CM, Friedland JS. The paradox of matrix metalloproteinases in infectious disease. Clin Exp Immunol 2005, 142:12-20. 10.1111/j.1365-2249.2005.02840.x, 1809491, 16178851.
2. Nagase H, Woessner JF. Matrix metalloproteinases. J Biol Chem 1999, 274:21491-21494. 10.1074/jbc.274.31.21491, 10419448.
3. Malemud CJ. Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci 2006, 11:1696-1701. 10.2741/1915, 16368548.
4. Cavallaro U, Dejana E. Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol 2011, 12:189-197. 10.1038/nrm3068, 21346732.
5. Somerville RP, Oblander SA, Apte SS. Matrix metalloproteinases: old dogs with new tricks. Genome Biol 2003, 4:216. 10.1186/gb-2003-4-6-216, 193609, 12801404.
6. Maitra SR, Bhaduri S, El-Maghrabi MR, Shapiro MJ. Inhibition of matrix metalloproteinase on hepatic transforming growth factor beta1 and caspase-3 activation in hemorrhage. Acad Emerg Med 2005, 12:797-803.
7. Vaday GG, Franitza S, Schor H, Hecht I, Brill A, Cahalon L, Hershkoviz R, Lider O. Combinatorial signals by inflammatory cytokines and chemokines mediate leukocyte interactions with extracellular matrix. J Leukoc Biol 2001, 69:885-892.
8. Opdenakker G, Van den Steen PE, Dubois B, Nelissen I, Van Coillie E, Masure S, Proost P, Van Damme J. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001, 69:851-859.
9. Pustovrh C, Jawerbaum A, Sinner D, Pesaresi M, Baier M, Micone P, Gimeno M, Gonzalez ET. Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus. Reprod Fertil Dev 2000, 12:269-275. 10.1071/RD00078, 11451017.
10. Novaro V, Pustovrh C, Colman-Lerner A, Radisky D, Lo Nostro F, Paz D, Jawerbaum A, Gonzalez E. Nitric oxide induces gelatinase A (matrix metalloproteinase 2) during rat embryo implantation. Fertil Steril 2002, 78:1278-1287. 10.1016/S0015-0282(02)04240-1, 12477525.
11. Jian Liu K, Rosenberg GA. Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 2005, 39:71-80. 10.1016/j.freeradbiomed.2005.03.033, 15925279.
12. Woessner JF. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991, 5:2145-2154.
13. Tyagi SC, Meyer L, Kumar S, Schmaltz RA, Reddy HK, Voelker DJ. Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions. Can J Cardiol 1996, 12:353-362.
14. Nemeth JA, Goolsby CL. TIMP-2, a growth-stimulatory protein from SV40-transformed human fibroblasts. Exp Cell Res 1993, 207:376-382. 10.1006/excr.1993.1204, 8393803.
15. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998, 101:1478-1487. 10.1172/JCI1584, 508704, 9502791.
16. Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 1997, 3:27-45. 10.1093/molehr/3.1.27, 9239706.
17. Alexander CM, Hansell EJ, Behrendtsen O, Flannery ML, Kishnani NS, Hawkes SP, Werb Z. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996, 122:1723-1736.
18. Polette M, Nawrocki B, Pintiaux A, Massenat C, Maquoi E, Volders L, Schaaps JP, Birembaut P, Foidart JM. Expression of gelatinases A and B and their tissue inhibitors by cells of early and term human placenta and gestational endometrium. Lab Invest 1994, 71:838-846.
19. Noguchi Y, Sato T, Hirata M, Hara T, Ohama K, Ito A. Identification and characterization of extracellular matrix metalloproteinase inducer in human endometrium during the menstrual cycle in vivo and in vitro. J Clin Endocrinol Metab 2003, 88:6063-6072. 10.1210/jc.2003-030457, 14671212.
20. Nakanishi A, Morita K, Oka M, Katsunuma N. Evidence against a possible involvement of the serine, and thiol proteases in the exocytotic mechanism of catecholamine secretion in cultured bovine adrenal medullary cells. Biochem Int 1986, 13:799-807.
21. Ganser GL, Stricklin GP, Matrisian LM. EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int J Dev Biol 1991, 35:453-461.
22. Reyes PA, Vargas M, García K, Rubilar P, Navarrete P, Fuentes P, Ríos M, Orihuela P, Vargas R, Rubio V, Heckels J, Christodoulides M, Cardenas H, Velasquez LA. Apoptosis related genes expressed in cultured Fallopian tube epithelial cells infectedin vitrowithNeisseria gonorrhoeae. Biol Res 2007, 40:319-327.
23. Witty JP, Wright JH, Matrisian LM. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 1995, 6:1287-1303. 301288, 8573787.
24. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ. The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 2001, 128:3117-3131. 2785713, 11688561.
25. Chin JR, Werb Z. Matrix metalloproteinases regulate morphogenesis, migration and remodeling of epithelium, tongue skeletal muscle and cartilage in the mandibular arch. Development 1997, 124:1519-1530.
26. Okamoto K, Mandai M, Mimura K, Murawaki Y, Yuasa I. The association of MMP-1, -3 and -9 genotypes with the prognosis of HCV-related hepatocellular carcinoma patients. Res Commun Mol Pathol Pharmacol 2005, 117-118:77-89.
27. Meijer MJ, Mieremet-Ooms MA, van Hogezand RA, Lamers CB, Hommes DW, Verspaget HW. Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-alpha single nucleotide gene polymorphisms in inflammatory bowel disease. World J Gastroenterol 2007, 13:2960-2966.
28. Spiecker M, Darius H, Liao JK. A functional role of I kappa B-epsilon in endothelial cell activation. J Immunol 2000, 164:3316-3322.
29. Zucker S, Drews M, Conner C, Foda HD, DeClerck YA, Langley KE, Bahou WF, Docherty AJ, Cao J. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 1998, 273:1216-1222. 10.1074/jbc.273.2.1216, 9422789.
30. Abraham LC, Dice JF, Lee K, Kaplan DL. Phagocytosis and remodeling of collagen matrices. Exp Cell Res 2007, 313:1045-1055. 10.1016/j.yexcr.2006.12.019, 2700050, 17276428.
31. Troeberg L, Tanaka M, Wait R, Shi YE, Brew K, Nagase H. E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A). Biochemistry 2002, 41:15025-15035. 10.1021/bi026454l, 12475252.
32. Farr M, Pieper M, Calvete J, Tschesche H. The N-terminus of collagenase MMP-8 determines superactivity and inhibition: a relation of structure and function analyzed by biomolecular interaction analysis. Biochemistry 1999, 38:7332-7338. 10.1021/bi982618f, 10353844.
33. Morales P, Reyes P, Vargas M, Rios M, Imarai M, Cardenas H, Croxatto H, Orihuela P, Vargas R, Fuhrer J, et al. Infection of human fallopian tube epithelial cells with Neisseria gonorrhoeae protects cells from tumor necrosis factor alpha-induced apoptosis. Infect Immun 2006, 74:3643-3650. 10.1128/IAI.00012-06, 1479248, 16714596.
34. Velasquez L, Garcia K, Morales F, Heckels JE, Orihuela P, Rodas PI, Christodoulides M, Cardenas H. Neisseria gonorrhoeae pilus attenuates cytokine response of human fallopian tube explants. J Biomed Biotechnol 2012, 2012:491298. 3270410, 22318778.
35. Apte SS. A disintegrin-like and metalloprotease (reprolysin-type) with thrombospondin type 1 motif (ADAMTS) superfamily: functions and mechanisms. J Biol Chem 2009, 284:31493-31497. 10.1074/jbc.R109.052340, 2797218, 19734141.
36. Bentz H, Morris NP, Murray LW, Sakai LY, Hollister DW, Burgeson RE. Isolation and partial characterization of a new human collagen with an extended triple-helical structural domain. Proc Natl Acad Sci U S A 1983, 80:3168-3172. 10.1073/pnas.80.11.3168, 394001, 6574478.
37. Sellers A, Murphy G. Collagenolytic enzymes and their naturally occurring inhibitors. Int Rev Connect Tissue Res 1981, 9:151-190.
38. Imtiaz MT, Schripsema JH, Sigar IM, Kasimos JN, Ramsey KH. Inhibition of matrix metalloproteinases protects mice from ascending infection and chronic disease manifestations resulting from urogenital Chlamydia muridarum infection. Infect Immun 2006, 74:5513-5521. 10.1128/IAI.00730-06, 1594914, 16988226.
39. Newman PJ. The biology of PECAM-1. J Clin Invest 1997, 100:S25-S29. 10.1172/JCI119517, 9413397.
40. George SH, Greenaway J, Milea A, Clary V, Shaw S, Sharma M, Virtanen C, Shaw PA. Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers. J Pathol 2011, 225(1):106-117. 10.1002/path.2927, 21744340.